LONDON--(BUSINESS WIRE)--Technavio analysts forecast the global neurovascular stents market to grow to USD 1,072.16 million by 2021, at a CAGR of more than 13% over the forecast period, according to their latest report.

The research study by Technavio on the global neurovascular stents market for 2017-2021 provides detailed industry analysis based on the product type (carotid artery stents and intracranial stents), end-users (hospitals and ambulatory surgical centers), and geography (the Americas, EMEA, and APAC).

A neurovascular stent is a small, flexible, tube-like device made of fabric supported by a metal mesh. It is used to treat several conditions in the brain such as stenosis formation in the blood vessels and ischemic stroke, and aneurysm. The Americas occupy a majority 56% of the global market, driven by the presence of sophisticated healthcare infrastructure.
Technavio analysts highlight the following three factors that are contributing to the growth of the global neurovascular stents market:

Growing use of nitinol-based neurovascular stents
Advances in technology
Increase in demand for minimally invasive procedures
Growing use of nitinol-based neurovascular stents

“Nitinol is an alloy which allows manufacturers to achieve unique characteristics in undergoing a phase transformation when subjected to temperature changes, external forces, and mechanical loading, leading to its high adoption,” says Barath Palada, a lead analyst at Technavio for cardiovascular devices research.

Nitinol-based stents provide excellent biocompatibility, recovering elongation, visibility, and radiopacity (radiodensity) under X-ray fluoroscopy. Self-expanding stents have the added benefit of eliminating the need for high-pressure expansion making nitinol ideal for neurovascular stents.

Advances in technology

Rapid advances in technology have greatly fueled the adoption of neurovascular stents. The market has witnessed a shift to self-expanding stents for easy delivery and the development of drug-eluting stents to reduce in-stent stenosis. Further, the advancements in imaging technologies have paved the way for devising patient-specific plans for neurovascular treatments. Also, the integration of imaging technology during neurovascular procedures has allowed the better treatments with the use of stents. Such advances will drive the market growth.

Increase in demand for minimally invasive procedures

“The rise in demand for minimally invasive procedures with shorter recovery times has increased the adoption of neurovascular stents. The novel and innovative minimally invasive intracranial artery stenting is now the most adopted method for treating various cardiovascular diseases,” says Barath.

Also, minimally invasive (MI) procedures are less painful, offers quicker recovery, reduced hospital stays, and reduced incision marks. MI procedures are extremely precise and carry the risk of fewer post-surgery infections, bleeding, and complications. Minimally invasive surgeries along with magnetic resonance imaging (MRI) technology offer improved imaging and better insertion of stents.

Cardiology Homepage